Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

SHA:600789 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	717	772.54	798.46	688.81	576.85	647.69
Trading Asset Securities	-	1.22	1.19	1.26	1.21	1.09
Cash & Short-Term Investments	717	773.76	799.65	690.07	578.06	648.78
Cash Growth	-9.11%	-3.24%	15.88%	19.38%	-10.90%	-28.41%
Accounts Receivable	1,548	1,437	1,346	1,232	824.41	858.35
Other Receivables	325.89	354.78	14.97	18.42	31.36	38.87
Receivables	1,874	1,792	1,361	1,251	855.76	897.22
Inventory	1,259	1,484	1,406	1,481	1,208	869.07
Prepaid Expenses	-	3.98	2.82	1.29	-	-
Other Current Assets	67.08	76.54	78.32	86.17	109.49	92.3
Total Current Assets	3,917	4,130	3,648	3,509	2,751	2,507
Property, Plant & Equipment	3,820	3,833	3,887	4,047	3,921	3,750
Long-Term Investments	84.44	88	103.13	89.84	69.67	89.32
Other Intangible Assets	784.08	766.2	724.04	603.01	570.13	395.08
Long-Term Deferred Tax Assets	22.71	24.03	31.02	25.98	21.66	18.82
Long-Term Deferred Charges	150.77	128.4	107.79	148.58	170.17	187.17
Other Long-Term Assets	108.41	128.52	301.58	304.76	318.47	325.55
Total Assets	8,887	9,098	8,802	8,728	7,822	7,273
Accounts Payable	1,269	1,503	1,503	1,611	1,164	1,154
Accrued Expenses	45.7	144.57	140.38	145.08	104.27	99.47
Short-Term Debt	915.13	871.77	1,102	1,344	1,282	1,560
Current Portion of Long-Term Debt	-	282.56	464.63	640.6	673.07	44.74
Current Portion of Leases	-	-	-	1.57	0.88	-
Current Income Taxes Payable	-	1.97	5.9	4.67	5.46	10.45
Current Unearned Revenue	61.08	167.61	209.08	216.6	129.49	95.32
Other Current Liabilities	854.83	89.76	92.2	165.3	118.36	162.35
Total Current Liabilities	3,146	3,061	3,517	4,129	3,478	3,126
Long-Term Debt	1,364	1,686	1,309	867.18	692.4	550.95
Long-Term Leases	-	-	-	-	0.62	25.81
Long-Term Unearned Revenue	162.48	165.72	110.97	100.41	99.04	83.64
Other Long-Term Liabilities	123.86	123.86	123.86	123.86	123.86	126.66
Total Liabilities	4,796	5,036	5,061	5,220	4,394	3,914
Common Stock	898.67	898.67	896.04	886.88	880.6	880.23
Additional Paid-In Capital	1,698	1,698	1,683	1,630	1,653	1,632
Retained Earnings	1,369	1,342	1,047	849.26	755.36	702.64
Comprehensive Income & Other	-22.09	-21.06	-14.29	-9.59	-5.58	-0.99
Total Common Equity	3,944	3,918	3,612	3,357	3,283	3,214
Minority Interest	147.2	143.39	129.65	150.31	145.17	145.29
Shareholders' Equity	4,091	4,062	3,741	3,507	3,428	3,359
Total Liabilities & Equity	8,887	9,098	8,802	8,728	7,822	7,273
Total Debt	2,279	2,840	2,876	2,854	2,649	2,181
Net Cash (Debt)	-1,562	-2,066	-2,076	-2,164	-2,071	-1,533
Net Cash Per Share	-1.76	-2.30	-2.36	-2.35	-2.32	-1.68
Filing Date Shares Outstanding	907.28	898.67	896.04	886.88	880.6	880.23
Total Common Shares Outstanding	907.28	898.67	896.04	886.88	880.6	880.23
Working Capital	770.92	1,069	130.46	-620.23	-727.25	-619.14
Book Value Per Share	4.35	4.36	4.03	3.79	3.73	3.65
Tangible Book Value	3,160	3,152	2,888	2,754	2,713	2,819
Tangible Book Value Per Share	3.48	3.51	3.22	3.11	3.08	3.20
Buildings	-	2,222	2,100	1,975	1,802	1,634
Machinery	-	3,803	3,629	3,503	3,054	2,859
Construction In Progress	-	121.86	100.97	175.53	359.25	263.75

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.